You are here: Home » News-CM » Equities » Hot Pursuit
Business Standard

Cadila Healthcare corrects on profit booking

Capital Market 

fell 2.63% to Rs 400.20 at 15:00 on on profit booking after a recent rally.

Meanwhile, the Sensex was up 132.61 points, or 0.50%, to 26,482.78.

On BSE, so far 24,000 shares were traded in the counter, compared with average daily volume of 70,800 shares in the past one quarter. The stock hit a high of Rs 414.60 and a low of Rs 399.10 so far during the day. The stock hit a 52-week high of Rs 429.45 on 1 November 2016. The stock hit a 52-week low of Rs 295.50 on 18 January 2016. The stock had outperformed the market over the past 30 days till 28 November 2016, falling 1.86% compared with the 5.66% decline in the Sensex. The scrip had also outperformed the market in past one quarter, rising 6.50% as against Sensex's 7.03% decline.

The large-cap company has equity capital of Rs 102.37 crore. Face value per share is Re 1.

Shares of rose 12.51% in five trading sessions to settle at Rs 411 yesterday, 28 November 2016, from its close of Rs 365.30 on 21 November 2016.

Cadila Healthcare's consolidated net profit fell 28.93% to Rs 337.60 crore on 3.08% increase in net sales to Rs 2336.30 crore in Q2 September 2016 over Q2 September 2015.

is a global pharmaceutical company that discovers, manufactures and markets a broad range of healthcare therapies.

Powered by Capital Market - Live News

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

RECOMMENDED FOR YOU

Cadila Healthcare corrects on profit booking

Cadila Healthcare fell 2.63% to Rs 400.20 at 15:00 IST on BSE on profit booking after a recent rally.

fell 2.63% to Rs 400.20 at 15:00 on on profit booking after a recent rally.

Meanwhile, the Sensex was up 132.61 points, or 0.50%, to 26,482.78.

On BSE, so far 24,000 shares were traded in the counter, compared with average daily volume of 70,800 shares in the past one quarter. The stock hit a high of Rs 414.60 and a low of Rs 399.10 so far during the day. The stock hit a 52-week high of Rs 429.45 on 1 November 2016. The stock hit a 52-week low of Rs 295.50 on 18 January 2016. The stock had outperformed the market over the past 30 days till 28 November 2016, falling 1.86% compared with the 5.66% decline in the Sensex. The scrip had also outperformed the market in past one quarter, rising 6.50% as against Sensex's 7.03% decline.

The large-cap company has equity capital of Rs 102.37 crore. Face value per share is Re 1.

Shares of rose 12.51% in five trading sessions to settle at Rs 411 yesterday, 28 November 2016, from its close of Rs 365.30 on 21 November 2016.

Cadila Healthcare's consolidated net profit fell 28.93% to Rs 337.60 crore on 3.08% increase in net sales to Rs 2336.30 crore in Q2 September 2016 over Q2 September 2015.

is a global pharmaceutical company that discovers, manufactures and markets a broad range of healthcare therapies.

Powered by Capital Market - Live News

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

image
Business Standard
177 22

Cadila Healthcare corrects on profit booking

fell 2.63% to Rs 400.20 at 15:00 on on profit booking after a recent rally.

Meanwhile, the Sensex was up 132.61 points, or 0.50%, to 26,482.78.

On BSE, so far 24,000 shares were traded in the counter, compared with average daily volume of 70,800 shares in the past one quarter. The stock hit a high of Rs 414.60 and a low of Rs 399.10 so far during the day. The stock hit a 52-week high of Rs 429.45 on 1 November 2016. The stock hit a 52-week low of Rs 295.50 on 18 January 2016. The stock had outperformed the market over the past 30 days till 28 November 2016, falling 1.86% compared with the 5.66% decline in the Sensex. The scrip had also outperformed the market in past one quarter, rising 6.50% as against Sensex's 7.03% decline.

The large-cap company has equity capital of Rs 102.37 crore. Face value per share is Re 1.

Shares of rose 12.51% in five trading sessions to settle at Rs 411 yesterday, 28 November 2016, from its close of Rs 365.30 on 21 November 2016.

Cadila Healthcare's consolidated net profit fell 28.93% to Rs 337.60 crore on 3.08% increase in net sales to Rs 2336.30 crore in Q2 September 2016 over Q2 September 2015.

is a global pharmaceutical company that discovers, manufactures and markets a broad range of healthcare therapies.

Powered by Capital Market - Live News

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

image
Business Standard
177 22

Upgrade To Premium Services

Welcome User

Business Standard is happy to inform you of the launch of "Business Standard Premium Services"

As a premium subscriber you get an across device unfettered access to a range of services which include:

  • Access Exclusive content - articles, features & opinion pieces
  • Weekly Industry/Genre specific newsletters - Choose multiple industries/genres
  • Access to 17 plus years of content archives
  • Set Stock price alerts for your portfolio and watch list and get them delivered to your e-mail box
  • End of day news alerts on 5 companies (via email)
  • NEW: Get seamless access to WSJ.com at a great price. No additional sign-up required.
 

Premium Services

In Partnership with

 

Dear Guest,

 

Welcome to the premium services of Business Standard brought to you courtesy FIS.
Kindly visit the Manage my subscription page to discover the benefits of this programme.

Enjoy Reading!
Team Business Standard